04:33 PM EDT, 04/01/2024 (MT Newswires) -- Omeros ( OMER ) reported a Q4 net loss late Monday of $0.15 per diluted share, compared with earnings of $2.05 a year earlier.

Two analysts polled by Capital IQ expected a net loss of $0.56.

As expected, the biopharmaceutical company did not record any revenue during the quarter ended Dec. 31 or a year earlier.

For Q1, the company is projecting a net loss per share of $0.58 to $0.63. Analyst estimates were not available.

Omeros ( OMER ) said it had $171.8 million of cash available for operations as of Dec. 31.

The shares of the company were 1.6% higher in extended trading.

Price: 3.24, Change: +0.05, Percent Change: +1.57